GL1X · GenesisL1 explorer

MolNFT v1 · #120750 · protein

Crystal structure-based design and disovery of a novel PARP1 antiagonist (bl-PA10) that induces apoptosis and inhibits metastasis in triple negative breast cancer

5HA9 · Poly [ADP-ribose] polymerase 1: “Crystal structure-based design and disovery of a novel PARP1 antiagonist (bl-PA10) that induces apoptosis and…”. X-ray diffraction, 2 ligands (TP0, SO4), 9 pockets (best druggability 0.80). MolNFT v1…

PDB
5HA9
Type
protein
Length
702 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 1
EC
2.4.2.30
UniProt
P09874
Ligands
TP0, SO4
Pockets
9 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPoly [ADP-ribose] polymerase 1 (EC 2.4.2.30)protein35136% helix, 22% strandP09874

Ligands and binding sites

  • TP0 · Amitriptyline · ligand · chains B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13640.800.8936GOL, TP0
23580.790.8942GOL, SO4
32940.730.8632empty
4930.500.8318empty
51380.470.7830empty

Interfaces

1 interface between chains.

  • A–B · 973 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 5HA9 · Crystal structure-based design and disovery of a novel PARP1 antiagonist (BL-PA10) that… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.